IL58621A0 - Pharmaceutical compositions comprising aryltrifluoroethanol derivatives - Google Patents

Pharmaceutical compositions comprising aryltrifluoroethanol derivatives

Info

Publication number
IL58621A0
IL58621A0 IL58621A IL5862179A IL58621A0 IL 58621 A0 IL58621 A0 IL 58621A0 IL 58621 A IL58621 A IL 58621A IL 5862179 A IL5862179 A IL 5862179A IL 58621 A0 IL58621 A0 IL 58621A0
Authority
IL
Israel
Prior art keywords
aryltrifluoroethanol
derivatives
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL58621A
Other languages
English (en)
Original Assignee
Science Union & Cie
Rech Medicale Science Union Et
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie, Rech Medicale Science Union Et filed Critical Science Union & Cie
Publication of IL58621A0 publication Critical patent/IL58621A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
IL58621A 1978-11-03 1979-11-02 Pharmaceutical compositions comprising aryltrifluoroethanol derivatives IL58621A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
IL58621A0 true IL58621A0 (en) 1980-02-29

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
IL58621A IL58621A0 (en) 1978-11-03 1979-11-02 Pharmaceutical compositions comprising aryltrifluoroethanol derivatives
IL58620A IL58620A (en) 1978-11-03 1979-11-02 Aryltrifluoroethanol derivatives,their preparation and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL58620A IL58620A (en) 1978-11-03 1979-11-02 Aryltrifluoroethanol derivatives,their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (2) US4285943A (de)
JP (2) JPS5566510A (de)
AR (2) AR223989A1 (de)
AT (1) AT368483B (de)
AU (1) AU527630B2 (de)
BE (2) BE879787A (de)
CA (2) CA1139763A (de)
CH (2) CH647225A5 (de)
DD (2) DD151445A5 (de)
DE (2) DE2944294A1 (de)
DK (2) DK461579A (de)
EG (1) EG14114A (de)
ES (1) ES485656A0 (de)
FI (2) FI793444A (de)
FR (1) FR2440353A1 (de)
GB (2) GB2034587B (de)
GR (2) GR68015B (de)
IL (2) IL58621A0 (de)
IT (2) IT7950715A0 (de)
MA (2) MA18628A1 (de)
NL (2) NL7908099A (de)
NZ (2) NZ192020A (de)
OA (2) OA06372A (de)
PT (2) PT70408A (de)
SE (2) SE7909106L (de)
SU (1) SU925247A3 (de)
ZA (2) ZA795870B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
NZ595080A (en) 2009-02-16 2013-09-27 Giuliani Int Ltd Methods of treating hair related conditions
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
CN104284655B (zh) 2012-04-18 2017-10-27 诺格拉制药有限公司 治疗乳糖不耐受的方法
CA3128302A1 (en) 2019-02-08 2020-08-13 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
ES474002A1 (es) * 1977-10-07 1979-10-16 Science Union & Cie Procedimiento de preparacion de nuevos derivados de acidos arilalcanoicos y de sus sales con una base mineral u organi-ca

Also Published As

Publication number Publication date
US4404215A (en) 1983-09-13
DD147048A5 (de) 1981-03-18
US4285943A (en) 1981-08-25
GB2034587B (en) 1983-02-09
BE879787A (fr) 1980-04-30
AU527630B2 (en) 1983-03-17
DD151445A5 (de) 1981-10-21
GB2038802A (en) 1980-07-30
NL7908101A (nl) 1980-05-07
AT368483B (de) 1982-10-11
IT7950714A0 (it) 1979-10-31
GB2034587A (en) 1980-06-11
GR68015B (de) 1981-10-27
OA06372A (fr) 1981-08-31
ES8101538A1 (es) 1980-12-16
MA18629A1 (fr) 1980-07-01
AR223989A1 (es) 1981-10-15
DE2944294A1 (de) 1980-05-08
MA18628A1 (fr) 1980-07-01
EG14114A (en) 1983-03-31
IL58620A0 (en) 1980-02-29
SE7909106L (sv) 1980-05-04
DK461579A (da) 1980-05-04
DE2944293A1 (de) 1980-05-08
FI793445A (fi) 1980-05-04
NZ192020A (en) 1982-12-21
AU5241679A (en) 1980-05-08
PT70407A (en) 1979-12-01
DK461679A (da) 1980-05-04
CH641043A5 (fr) 1984-02-15
SU925247A3 (ru) 1982-04-30
BE879786A (fr) 1980-04-30
NZ192021A (en) 1982-09-07
ATA701679A (de) 1982-02-15
GB2038802B (en) 1982-12-08
SE7909105L (sv) 1980-05-04
JPS5566548A (en) 1980-05-20
ES485656A0 (es) 1980-12-16
NL7908099A (nl) 1980-05-07
IL58620A (en) 1982-12-31
FI793444A (fi) 1980-05-04
GR69726B (de) 1982-07-09
IT7950715A0 (it) 1979-10-31
PT70408A (fr) 1979-12-01
FR2440353A1 (fr) 1980-05-30
ZA795871B (en) 1980-10-29
CA1142087A (fr) 1983-03-01
CH647225A5 (fr) 1985-01-15
ZA795870B (en) 1980-10-29
JPS5566510A (en) 1980-05-20
AR223990A1 (es) 1981-10-15
OA06373A (fr) 1981-08-31
CA1139763A (fr) 1983-01-18

Similar Documents

Publication Publication Date Title
GB2039738B (en) Inflammation - preventing pharmaceutical composition
NZ189574A (en) Dehydrocyclicimino acid derivatives pharmaceutical compositions
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
JPS54132223A (en) Novel pharmaceutical composition
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
NZ191044A (en) Imidazole derivatives pharmaceutical compositions
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
ZA787000B (en) Pharmaceutical formulation
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
NZ189939A (en) N-oxacyclic-alkylpiperidyl-diaza compounds pharmaceutical compositions
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
IL56577A0 (en) Pharmaceutical compositions comprising certain pyrrolidinederivatives
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
ZA79395B (en) Pharmaceutical formulations
NZ191140A (en) 1-phenylpiperazine derivatives pharmaceutical compositions
GB2011785A (en) Coated pharmaceutical compositions
IL58621A0 (en) Pharmaceutical compositions comprising aryltrifluoroethanol derivatives
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
JPS54154516A (en) Pharmaceutical composition
NZ191048A (en) 1-benzoyl-3-pyridinyl-urea derivatives isecticidal compositions
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
JPS5527168A (en) Drug composition